Search Results - "Figeac, M"

Persistence of Coxsackievirus B4 in pancreatic ductal-like cells results in cellular and viral changes by Alidjinou, E. K., Engelmann, I., Bossu, J., Villenet, C., Figeac, M., Romond, M.-B., Sané, F., Hober, D.

“…Introduction: Although known as cytolytic viruses, group B coxackieviruses (CVB) are able to establish a persistent infection in vitro and in vivo. Viral…”
Get full text

BCL2 expression but not MYC and BCL2 coexpression predicts survival in elderly patients with diffuse large B-cell lymphoma independently of cell of origin in the phase 3 LNH03-6B trial by Petrella, T., Copie-Bergman, C., Brière, J., Delarue, R., Jardin, F., Ruminy, P., Thieblemont, C., Figeac, M., Canioni, D., Feugier, P., Fabiani, B., Leroy, K., Parrens, M., André, M., Haioun, C., Salles, G.A., Gaulard, P., Tilly, H., Jais, J.P., Molina, T.J.

“…Our aim was to evaluate whether the cell of origin (COO) as defined by the Hans algorithm and MYC/BCL2 coexpression, which are the two main biological risk…”
Get full text

HOXA9 transcription factor as a target in acute myeloid leukemia: Transcription, cellular and in vivo consequences of its invalidation by Lambert, M, Jambon, S, Depauw, S, Bouhlel, M.A, Figeac, M, David-Cordonnier, M.H

“…An abstract of the study by Lambert et al examining the molecular mechanisms by which HOXA9 blocks normal hematopoiesis differentiation, is presented. It has…”
Get full text

Molecular prognostic factors in acute myeloid leukemia receiving first-line therapy with azacitidine by Desoutter, J, Gay, J, Berthon, C, Ades, L, Gruson, B, Geffroy, S, Plantier, I, Marceau, A, Helevaut, N, Fernandes, J, Bemba, M, Stalnikiewicz, L, Frimat, C, Labreuche, J, Nibourel, O, Roumier, C, Figeac, M, Fenaux, P, Quesnel, B, Renneville, A, Duhamel, A, Preudhomme, C

Get full text

The costimulatory molecule CD70 is regulated by distinct molecular mechanisms and is associated with overall survival in diffuse large B-cell lymphoma by Bertrand, P., Maingonnat, C., Penther, D., Guney, S., Ruminy, P., Picquenot, J. M., Mareschal, S., Alcantara, M., Bouzelfen, A., Dubois, S., Figeac, M., Bastard, C., Tilly, H., Jardin, F.

“…In diffuse large B‐cell lymphomas (DLBCL), a recurrent deletion of the 19p13 region has recently been described. CD70 and TNFSF9 genes are suspected tumor…”
Get full text

P1257: MOLECULAR CHARACTERIZATION AND CLONAL EVOLUTION OF MYCOSIS FUNGOIDES by Fléchon, L., Arib, I., Dutta, A., Sklanvenitis Pistofidis, R., Stewart, C., Dubois, R., Poulain, S., Copin, M.‐C., Javed, S., Nudel, M., Hasan Bou Issa, L., Ouelkite‐Oumouchal, A., Faiz, S., Carpentier, O., Mortier, L., Mitra, S., Figeac, M., Morschhauser, F., Quesnel, B., Ghobrial, I., Manier, S.

Get full text

Recurrent genomic aberrations combined with deletions of various tumour suppressor genes may deregulate the G1 S transition in CD4+CD56+ haematodermic neoplasms and contribute to the aggressiveness of the disease by Jardin, F, Callanan, M, Penther, D, Ruminy, P, Troussard, X, Kerckaert, J P, Figeac, M, Parmentier, F, Rainville, V, Vaida, I, Bertrand, P, Duval, A B, Picquenot, J M, Chaperot, L, Marolleau, J P, Plumas, J, Tilly, H, Bastard, C

“…CD4+CD56+ haematodermic neoplasms (HDN) constitute a rare disease characterized by aggressive clinical behaviour and a poor prognosis. Tumour cells from HDN…”
Get full text

PO-133 Hoxa9 transcription factor: a potential novel therapeutic target in renal cell carcinoma (RCC) by Jambon, S, Lambert, M, Depauw, S, Figeac, M, Perrais, M, David-Cordonnier, MH

“…IntroductionKidney cancer represents 2%–3% of all cancer cases and is an insidious cancer with poor prognosis in metastatic stages associated with chemo- and…”
Get full text

Waved aCGH: to smooth or not to smooth by Leprêtre, F, Villenet, C, Quief, S, Nibourel, O, Jacquemin, C, Troussard, X, Jardin, F, Gibson, F, Kerckaert, J.P, Roumier, C, Figeac, M

“…Array-based comparative genomic hybridization (aCGH) is a powerful tool to detect genomic imbalances in the human genome. The analysis of aCGH data sets has…”
Get full text

3.262 DEREGULATION OF GENE EXPRESSION IN PERIPHERAL BLOOD MONONUCLEAR CELLS AT DIFFERENT STAGES OF THE PARKINSON'S DISEASE by Mutez, E, Duflot, A, Figeac, M, Hot, D, Blervaque,, R, Vanbesien-Mailliot, C, Semaille, P, Simonin, C, Kreisler, A, Destée, A, Chartier-Harlin, M.-C

Get full text

3.074 TRANSCRIPTOME PROFILING OF BLOOD MONONUCLEAR CELLS FROM SCA2 PATIENTS ACCORDING TO CEREBELLAR OR PARKINSONIAN PHENOTYPES by Simonin, C, Mutez, E, Sablonnière, B, Duflot, A, Figeac, M, Lepretre, F, Defebvre, L, Kreisler, A, Vanbesien-Mailliot, C, Devos, D, Frigard, B, Destée, A, Chartier-Harlin, M.-C

Get full text

282 Familial myelodysplastic syndrome/acute myeloid leukemia (MDS/AML): Report of 2 families by Bastard, A. Stamatoullas, Loschi, M, Figeac, M, Penther, D, Callat, M.P, Lepretre, S, Lenain, P, Contentin, N, Tilly, H, Bastard, C

Get full text

Recurrent genomic aberrations combined with deletions of various tumour suppressor genes may deregulate the G1 S transition in CD4+CD56+ haematodermic neoplasms and contribute to the aggressiveness of the disease by Callanan, M, Penther, D, Plumas, J, Vaida, I, Picquenot, J.M, Kerckaert, J.P, Rainville, V, Duval, A.B, Troussard, X, Marolleau, J.P, Tilly, H, Bertrand, P, Figeac, M, Chaperot, L, Bastard, C, Parmentier, F, Jardin, F, Ruminy, P

“…Corrigenda: no abstract…”
Get full text

P20-06 Profile signatures of circulating miRNAs and contribution of organ-specific miRNAs in a mouse model chronically exposed to air pollution-derived ultrafine particles by Barbier, E., Carpentier, J., Simonin, O., Figeac, M., Anthérieu, S., Alleman, L.Y., Perdrix, E., Lo Guidice, J.-M., Garçon, G.

“…Indoor environmental exposure to pesticides has become one of the major concerns that might adversely affect human health and development. People spend most of…”
Get full text

P14-03: Transcriptomic alterations induced by air pollution-derived ultrafine particles in lungs of mice chronically exposed by Barbier, E., Carpentier, J., Simonin, O., Figeac, M., Sebda, S., Alleman, L.Y., Perdrix, E., Lo-Guidice, J.-M., Antherieu, S., Garçon, G.

Get full text

49 - HOXA9 transcription factor as a target in acute myeloid leukemia: Transcription, cellular and in vivo consequences of its invalidation by Lambert, M., Jambon, S., Depauw, S., Bouhlel, M.A., Figeac, M., David-Cordonnier, M.H.

Get full text

Growth-restriction during lactation disrupts the intestinal clock and gut homeostasis but is not prevented by lactoferrin supplementation by Tran, L.C., Marousez, L., Micours, E., Dubernat, L., Meneboo, J.-P., Figeac, M., Bonhomme, C., Gottrand, F., Lesage, J., Ley, D.

Get full text

Comprehensive molecular analysis of recurrence in gastrooesophageal adenocarcinoma by Renaud, F., Piessen, G., Figeac, M., Dejeante, C., Messier, M., Delattre, L., Adenis, A., Chatelain, Denis, Boulagnon-Rombi, C., Eveno, C., van Seuningen, I., Mariette, C., Leteurtre, E., Buisine, M.

Get full text

Erratum: Recurrent genomic aberrations combined with deletions of various tumour suppressor genes may deregulate the G1/S transition in CD4+CD56+ haematodermic neoplasms and contribute to the aggressiveness of the disease by Jardin, F, Callanan, M, Penther, D, Ruminy, P, Troussard, X, Kerckaert, J P, Figeac, M, Parmentier, F, Rainville, V, Vaida, I, Bertrand, P, Duval, A B, Picquenot, J M, Chaperot, L, Marolleau, J P, Plumas, J, Tilly, H, Bastard, C

“…Correction to: Leukemia (2009) 23, 698–707; doi:10.1038/leukemia.2008.359; published online 22 January 2009 Since the publication of this paper, the authors…”
Get full text

Non-English title by Choteau, L, Vasseur, F, Lepretre, F, Figeac, M, Dubuquoy, L, Poulain, D, Colombel, J, Sendid, B, Jawhara, S

“…Original Abstract: Introduction: La Mannose-binding lectine (MBL) est associee a des proteases a serine (MASP, MBL-associated serine protease) pour former un…”
Get full text